Neurology: Borna disease in Horses (Equis) | Vetlexicon
equis - Articles

Neurology: Borna disease

ISSN 2398-2977

Contributor(s) :


Synonym(s): Near Eastern Equine Encephalitis (NEEE)

Introduction

  • A rare, sporadic, severe neurological disease occurring in spring and early summer.
  • Cause: Borna disease virus (BDV) - classified by itself in theBornaviridaefamily.
  • Signs: abnormal mentation; compulsive behavior; circling; head pressing; depression; tremors; hyperesthesia; often progresses to convulsions or coma. 
  • Diagnosis: neurological examination; antibody testing of CSF and serum.
  • Treatment: symptomatic care.
  • Prognosis: grave high mortality; residual neurological deficits are common, necessitating euthanasia.

Presenting signs

  • Subclinical encephalitis, peracute encephalitis through transient ataxia and fever all occur.
  • Abnormal behavior.
  • Neurological signs.
  • Depression.

Acute presentation

  • Behavioral and mentation changes.
  • Signs of forebrain disease such as circlng, head-pressing, constant yawning, aggressiveness.
  • Asymmetric vestibular signs and various cranial nerve functional deficits.
  • Ataxia.
  • Dysphagia.
  • Hyperesthesia.
  • Seizures.
  • Coma.

Geographic incidence

  • Europe and the Middle East.
  • BDV-antibodies have been isolated from otherwise healthy horses in Israel, Japan and the USA, although the disease has not been recorded there.

Public health considerations

  • Cases in humans, sheep, cattle, goats, ostriches, rabbits and cats have been documented.

Cost considerations

  • Treatment is often unsuccessful.
  • Successful treatment is often prolonged and residual deficiencies are common, resulting in euthanasia several months down the line.

Pathogenesis

Etiology

  • Caused by Borna disease virus (BDV).
  • Cell-free virus has still to be isolated for full virology to be possible.
  • Route of infection is unknown - ? inhalation, ingestion, tick-borne.

Pathophysiology

  • Low morbidity.
  • The specific etiology of the development of the clinical disease is unknown, but thought to be the result of a virus-induced, cell-mediated, immunopathological reaction.
  • The virus can produce latent or persistent infections, or asymptomatic carrier states which may excrete the virus and be a potential risk to others.
  • High mortality around 80%.

Timecourse

  • A long incubation period of 4 weeks to 6 months before clinical signs.
  • Acute encephalitis phase usually lasts 1-3 weeks.
  • Full recovery is rare.

Epidemiology

  • Route of infection is unknown - ? inhalation, ingestion or tick-borne.
  • Cases are usually sporadic.
  • In-contacts or recovered animals may become asymptomatic carriers which can excrete the virus indefinitely.
  • ? Wild birds are implicated in transmission of the disease between populations.

Diagnosis

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Treatment

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Prevention

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Outcomes

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Priestnall S L et al (2011) Borna disease virus infection of a horse in Great Britain. Vet Rec 168 (14), 380 PubMed.